(Q41442026)

English

A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia

scientific article published on August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia (English)

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

traditional Chinese medicine

1 reference

object named as

traditional Chinese medicine

17 February 2024

based on heuristic

inferred from title

author name string

Shi-Fu Xiao

1

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

Hai-Bo Xue

2

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

Xia Li

3

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

Chao Chen

4

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

Guan-Jun Li

5

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

Cheng-Mei Yuan

6

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

Ming-Yuan Zhang

7

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

publication date

1 August 2011

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

Neuroscience Bulletin

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

27

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

4

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

258-268

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

Role of CREB in the regulatory action of sarsasapogenin on muscarinic M1 receptor density during cell aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Is schizophrenia a neurodegenerative disorder?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Negative symptoms in schizophrenia: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Schizophrenia: a concise overview of incidence, prevalence, and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Mitochondrial ROS burst as an early sign in sarsasapogenin-induced apoptosis in HepG2 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Schizophrenia: a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

The apoptotic effect of sarsasapogenin from Anemarrhena asphodeloides on HepG2 human hepatoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Negative symptoms of schizophrenia: a problem that will not go away

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Strategies for maximizing clinical effectiveness in the treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

Persistent negative symptoms in schizophrenia: an overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

A new approach to the pharmacological regulation of memory: Sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

A review of MRI findings in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

1 October 2017

TLC-densitometric determination of sarsasapogenin in Anemarrhena asphodeloides Bge.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

11 June 2018

Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

11 June 2018

Replication of factor structure of Wechsler Adult Intelligence Scale-III Chinese version in Chinese mainland non-clinical and schizophrenia samples.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

19 August 2018

Antidepressant activity of sarsasapogenin from Anemarrhena asphodeloides Bunge (Liliaceae).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

19 August 2018

Schizophrenia: a neurodevelopmental or a neurodegenerative disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

19 August 2018

Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

19 August 2018

Effect of sarsasapogenin and its derivatives on the stimulus coupled responses of human neutrophils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

19 August 2018

A new clinical scale for the staging of dementia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

19 August 2018

Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

19 August 2018

Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

2 references

https://api.crossref.org/works/10.1007%2FS12264-011-1417-6

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5560307

4 November 2018

The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788997

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788997

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Steroidal saponins from Asparagus filicinus]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788997

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12264-011-1417-6

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41442026&oldid=2204539145"